Could shorter antibiotic courses be safer for blood cancer patients?
NCT ID NCT07372131
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study looks at whether blood cancer patients with a serious infection can safely stop antibiotics sooner if they are stable for 72 hours, instead of the usual 10-day course. About 172 adults will be randomly assigned to either a personalized short course or standard long course. The goal is to see if shorter treatment reduces antibiotic use and side effects without increasing risks like infection return or death.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERAEMIA CAUSED BY GRAM-NEGATIVE BACTERIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Microbiology and Virology - IRCCS Humanitas Research Hospital
RECRUITINGRozzano, Milan, 20089, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Frailty check may steer safer cancer care for seniors
- Could gratitude exercises aid blood cancer recovery?
- Can a new tracer light up cancer growth?
- Could one blood draw be enough to catch dangerous infections?